Glucocorticoids
The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
The most effective anti-inflammatory drugs used to treat patients with airways disease are topical glucocorticosteroids (GCs). These act on virtually all cells within the airway to suppress airway inflammation or prevent the recruitment of inflammatory cells into the airway. They also have profound effects on airway structural cells to reverse the effects of disease on their function. Glucorticosteroids act via specific receptors-the glucocorticosteroid receptor (GR)-which are a member of the nuclear receptor family. As such, many of the important actions of GCs are to modulate gene transcription through a number of distinct and complementary mechanisms. Targets genes include most inflammatory mediators such as chemokines, cytokines, growth factors and their receptors. GCs delivered by the inhaled route are very effective for most patients and have few systemic side effects. However, in some patients, even high doses of topical or even systemic GCs fail to control their disease. A number of mechanisms relating to inflammation have been reported to be responsible for the failure of these patients to respond correctly to GCs and these provide insight into GC actions within the airways. In these patients, the side-effect profile of GCs prevent continued use of high doses and new drugs are needed for these patients. Targeting the defective pathways associated with GC function in these patients may also reactivate GC responsiveness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic glucocorticoid (GC) treatment represents a widely-prescribed therapy for several diseases in consideration of both anti-inflammatory and immunosuppressive activity”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [5]
In the citing paper
“Furthermore, GR-mediated feedback inhibition on the pituitary only occurs at chronic GC levels that incur adverse peripheral effects [5].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [5]
Citations
Cites
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., & Pavord, I. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403291 · Cited by 1,661
Lebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., Wang, L., Kirkesseli, S., Rocklin, R., Bock, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304048 · Cited by 1,320
Kino, T., Hurt, D. E., Ichijo, T., Nader, N., & Chrousos, G. P. (2010) · Science Signaling · doi:10.1126/scisignal.2000568 · Cited by 1,231
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
O'Shea, J. J., & Plenge, R. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.014 · Cited by 1,138
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Wenzel, S., Castro, M., Corren, J., Maspero, J., Wang, L., Zhang, B., Pirozzi, G., Sutherland, E. R., Evans, R. R., Joish, V. N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30307-5 · Cited by 985
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Self-citationDecreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968
Oxidative stress and redox regulation of lung inflammation in COPD
Rahman, I., & Adcock, I. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00053805 · Cited by 944
Moore, W. C., Bleecker, E. R., Curran-Everett, D., Erzurum, S. C., Ameredes, B. T., Bacharier, L., Calhoun, W. J., Castro, M., Chung, K. F., Clark, M. P., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.639 · Cited by 929
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
Barnes, P. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706736 · Cited by 838
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex
Lanz, R. B., McKenna, N. J., Onate, S. A., Albrecht, U., Wong, J., Tsai, S. Y., Tsai, M.-J., & O’Malley, B. W. (1999) · Cell · doi:10.1016/s0092-8674(00)80711-4 · Cited by 792
TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice
McKinley, L., Alcorn, J. F., Peterson, A., DuPont, R. B., Kapadia, S., Logar, A., Henry, A., Irvin, C. G., Piganelli, J. D., Ray, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4089 · Cited by 777
WENZEL, S. E., SZEFLER, S. J., LEUNG, D. Y. M., SLOAN, S. I., REX, M. D., & MARTIN, R. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9610046 · Cited by 754
Pascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., & Pavord, I. D. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00106-x · Cited by 743
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
DNA binding site sequence directs glucocorticoid receptor structure and activity
Meijsing, S. H., Pufall, M. A., So, A. Y., Bates, D. L., Chen, L., & Yamamoto, K. R. (2009) · Science · doi:10.1126/science.1164265 · Cited by 673
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638
Self-citationPeters, M. C., McGrath, K. W., Hawkins, G. A., Hastie, A. T., Levy, B. D., Israel, E., Phillips, B. R., Mauger, D. T., Comhair, S. A., Erzurum, S. C., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30048-0 · Cited by 543
Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding
Biddie, S. C., John, S., Sabo, P. J., Thurman, R. E., Johnson, T. A., Schiltz, R. L., Miranda, T. B., Sung, M.-H., Trump, S., Lightman, S. L., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.016 · Cited by 503
Wenzel, S. E., Barnes, P. J., Bleecker, E. R., Bousquet, J., Busse, W., Dahlén, S.-E., Holgate, S. T., Meyers, D. A., Rabe, K. F., Antczak, A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1512oc · Cited by 460
National Heart, Lung, and Blood Institute: Transitions
Nabel, E. G. (2009) · Circulation · doi:10.1161/circulationaha.108.841551 · Cited by 434
Irusen, E., Matthews, J. G., Takahashi, A., Barnes, P. J., Chung, K. F., & Adcock, I. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122465 · Cited by 416
Update on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 397
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
Guiducci, C., Gong, M., Xu, Z., Gill, M., Chaussabel, D., Meeker, T., Chan, J. H., Wright, T., Punaro, M., Bolland, S., et al. (2010) · Nature · doi:10.1038/nature09102 · Cited by 380
How Do Corticosteroids Work in Asthma?
Barnes, P. J., & Adcock, I. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00012 · Cited by 371
To, Y., Ito, K., Kizawa, Y., Failla, M., Ito, M., Kusama, T., Elliott, W. M., Hogg, J. C., Adcock, I. M., & Barnes, P. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0937oc · Cited by 352
Pharmacology of the Eosinophil
Giembycz, M. A., & Lindsay, M. A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01404-2 · Cited by 351
Asthma exacerbations: Origin, effect, and prevention
Jackson, D. J., Sykes, A., Mallia, P., & Johnston, S. L. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.024 · Cited by 343
Bel, E. H., Sousa, A., Fleming, L., Bush, A., Chung, K. F., Versnel, J., Wagener, A. H., Wagers, S. S., Sterk, P. J., Compton, C. H., et al. (2011) · Thorax · doi:10.1136/thx.2010.153643 · Cited by 343
Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma
Peters, M. C., Mekonnen, Z. K., Yuan, S., Bhakta, N. R., Woodruff, P. G., & Fahy, J. V. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.036 · Cited by 342
Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity
Kato, A., & Schleimer, R. P. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.08.004 · Cited by 336
Cross‐talk between pro‐inflammatory transcription factors and glucocorticoids
Adcock, I. M., & Caramori, G. (2001) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2001.01025.x · Cited by 330
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
Pavord, I. D., Lettis, S., Locantore, N., Pascoe, S., Jones, P. W., Wedzicha, J. A., & Barnes, N. C. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207021 · Cited by 327
Lung Dendritic Cells in Respiratory Viral Infection and Asthma: From Protection to Immunopathology
Lambrecht, B. N., & Hammad, H. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075021 · Cited by 302
Corticosteroids: The drugs to beat
Barnes, P. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.052 · Cited by 301
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
Daley‐Yates, P. T. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12637 · Cited by 260
Glucocorticoid receptor isoforms generate transcription specificity
Lu, N. Z., & Cidlowski, J. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.005 · Cited by 248
The Cost of Persistent Asthma in Europe: An International Population-Based Study in Adults
Accordini, S., Corsico, A. G., Braggion, M., Gerbase, M. W., Gislason, D., Gulsvik, A., Heinrich, J., Janson, C., Jarvis, D., Jõgi, R., et al. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000338998 · Cited by 241
Inhibition of PI3Kδ Restores Glucocorticoid Function in Smoking-induced Airway Inflammation in Mice
Marwick, J. A., Caramori, G., Stevenson, C. S., Casolari, P., Jazrawi, E., Barnes, P. J., Ito, K., Adcock, I. M., Kirkham, P. A., & Papi, A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1570oc · Cited by 238
New targets for drug development in asthma
Adcock, I. M., Caramori, G., & Chung, K. F. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61449-x · Cited by 233
Epithelial cells and airway diseases
Proud, D., & Leigh, R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01033.x · Cited by 229
p38 Mitogen-Activated Protein Kinase Pathways in Asthma and COPD
Chung, K. F. (2011) · Chest · doi:10.1378/chest.10-1914 · Cited by 227
Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor
Savory, J. G. A., Hsu, B., Laquian, I. R., Giffin, W., Reich, T., Haché, R. J. G., & Lefebvre, Y. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1025 · Cited by 222
Importin 7 and Importin α/Importin β Are Nuclear Import Receptors for the Glucocorticoid Receptor
Freedman, N. D., & Yamamoto, K. R. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0839 · Cited by 213
Kaminska, M., Foley, S., Maghni, K., Storness-Bliss, C., Coxson, H., Ghezzo, H., Lemière, C., Olivenstein, R., Ernst, P., Hamid, Q., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.049 · Cited by 210
A new look at the pathogenesis of asthma
Holgate, S. T., Arshad, H. S., Roberts, G. C., Howarth, P. H., Thurner, P., & Davies, D. E. (2010) · Clinical Science · doi:10.1042/cs20090474 · Cited by 209
McNicholl, D. M., Stevenson, M., McGarvey, L. P., & Heaney, L. G. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0587oc · Cited by 196
Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions
Weigel, N. L., & Moore, N. L. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0101 · Cited by 196
Urry, Z., Chambers, E. S., Xystrakis, E., Dimeloe, S., Richards, D. F., Gabryšová, L., Christensen, J., Gupta, A., Saglani, S., Bush, A., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201242370 · Cited by 192
Langlais, D., Couture, C., Balsalobre, A., & Drouin, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.021 · Cited by 191
Treatment Effects of Low-Dose Theophylline Combined With an Inhaled Corticosteroid in COPD
Ford, P. A., Durham, A. L., Russell, R. E. K., Gordon, F., Adcock, I. M., & Barnes, P. J. (2010) · Chest · doi:10.1378/chest.09-2363 · Cited by 190
Defective Phagocytosis in Airways Disease
Donnelly, L. E., & Barnes, P. J. (2012) · Chest · doi:10.1378/chest.11-2348 · Cited by 190
The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma
Hewitt, R., Farne, H., Ritchie, A., Luke, E., Johnston, S. L., & Mallia, P. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465815618113 · Cited by 186
Direct GR Binding Sites Potentiate Clusters of TF Binding across the Human Genome
Vockley, C. M., D’Ippolito, A. M., McDowell, I. C., Majoros, W. H., Safi, A., Song, L., Crawford, G. E., & Reddy, T. E. (2016) · Cell · doi:10.1016/j.cell.2016.07.049 · Cited by 182
Kino, T., Su, Y. A., & Chrousos, G. P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0098-z · Cited by 179
Smoak, K., & Cidlowski, J. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00679-06 · Cited by 175
Glucocorticoids induce mitochondrial gene transcription in HepG2 cells
Psarra, A.-M. G., & Sekeris, C. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.05.014 · Cited by 174
Glucocorticoid receptor localization in normal and asthmatic lung.
Adcock, I. M., Gilbey, T., Gelder, C. M., Chung, K. F., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810618 · Cited by 171
Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Zijlstra, G. J., ten Hacken, N. H. T., Hoffmann, R. F., van Oosterhout, A. J. M., & Heijink, I. H. (2012) · European Respiratory Journal · doi:10.1183/09031936.00017911 · Cited by 170
Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2
Osoata, G. O., Yamamura, S., Ito, M., Vuppusetty, C., Adcock, I. M., Barnes, P. J., & Ito, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.128 · Cited by 168
Galliher-Beckley, A. J., Williams, J. G., & Cidlowski, J. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05866-11 · Cited by 164
Gene Expression Patterns of Th2 Inflammation and Intercellular Communication in Asthmatic Airways
Choy, D. F., Modrek, B., Abbas, A. R., Kummerfeld, S., Clark, H. F., Wu, L. C., Fedorowicz, G., Modrusan, Z., Fahy, J. V., Woodruff, P. G., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002568 · Cited by 161
Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma
Umland, S. P., Schleimer, R. P., & Johnston, S. L. (2002) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0312 · Cited by 159
Glucocorticoids Suppress Inflammation but Spare Innate Immune Responses in Airway Epithelium
Schleimer, R. P. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200402-018ms · Cited by 157
Goleva, E., Hauk, P. J., Hall, C. F., Liu, A. H., Riches, D. W. H., Martin, R. J., & Leung, D. Y. M. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.007 · Cited by 155
Airway Smooth Muscle Hyperproliferation Is Regulated by MicroRNA-221 in Severe Asthma
Perry, M. M., Baker, J. E., Gibeon, D. S., Adcock, I. M., & Chung, K. F. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0067oc · Cited by 148
Dynamic regulation of glucocorticoid signalling in health and disease
Biddie, S. C., Conway-Campbell, B. L., & Lightman, S. L. (2012) · Rheumatology · doi:10.1093/rheumatology/ker215 · Cited by 143
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
Durham, A. L., Caramori, G., Chung, K. F., & Adcock, I. M. (2015) · Translational research · doi:10.1016/j.trsl.2015.08.004 · Cited by 140
Targeting the Epigenome in the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200907-071dp · Cited by 140
Chung, K. F. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-028sr · Cited by 138
Hallett, J. M., Leitch, A. E., Riley, N. A., Duffin, R., Haslett, C., & Rossi, A. G. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.002 · Cited by 134
Ledderose, C., Möhnle, P., Limbeck, E., Schütz, S., Weis, F., Rink, J., Briegel, J., & Kreth, S. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825b8ebc · Cited by 130
Li, L.-B., Goleva, E., Hall, C. F., Ou, L.-S., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.005 · Cited by 127
How the Lung Handles Drugs: Pharmacokinetics and Pharmacodynamics of Inhaled Corticosteroids
Winkler, J., Hochhaus, G., & Derendorf, H. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200403-025ms · Cited by 124
Spears, M., Donnelly, I., Jolly, L., Brannigan, M., Ito, K., McSharry, C., Lafferty, J., Chaudhuri, R., Braganza, G., Adcock, I. M., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00158208 · Cited by 122
Oral prednisone therapy in experimental rhinovirus infections
Gustafson, L. M., Proud, D., Hendley, J. O., Hayden, F. G., & Gwaltney, J. M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80077-7 · Cited by 122
Intrinsic asthma: not so different from allergic asthma but driven by superantigens?
Barnes, P. J. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03298.x · Cited by 121
Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses
Xavier, A. M., Anunciato, A. K. O., Rosenstock, T. R., & Glezer, I. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00031 · Cited by 118
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
Bhavsar, P. K., Khorasani, N. M., Hew, M. J., Johnson, M., & Chung, K. F. (2009) · European Respiratory Journal · doi:10.1183/09031936.00071309 · Cited by 112
GRÜNBERG, K., SHARON, R. F., SONT, J. K., IN'T VEEN, J. C. C. M., VAN SCHADEWIJK, W. A. A. M., DE KLERK, E. P. A., DICK, C. R., VAN KRIEKEN, J. H. J. M., & STERK, P. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2102118 · Cited by 109
Cross Talk of Signaling Pathways in the Regulation of the Glucocorticoid Receptor Function
Davies, L., Karthikeyan, N., Lynch, J. T., Sial, E.-A., Gkourtsa, A., Demonacos, C., & Krstic-Demonacos, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0360 · Cited by 109
Zhang, N., Truong-Tran, Q. A., Tancowny, B., Harris, K. E., & Schleimer, R. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.578 · Cited by 100
Li, L.-B., Leung, D. Y. M., Martin, R. J., & Goleva, E. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0015oc · Cited by 99
Role of the RNA-Binding Protein Tristetraprolin in Glucocorticoid-Mediated Gene Regulation
Ishmael, F. T., Fang, X., Galdiero, M. R., Atasoy, U., Rigby, W. F. C., Gorospe, M., Cheadle, C., & Stellato, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8342 · Cited by 96
Heaney, L. G., Djukanovic, R., Woodcock, A., Walker, S., Matthews, J. G., Pavord, I. D., Bradding, P., Niven, R., Brightling, C. E., Chaudhuri, R., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207326 · Cited by 96
Papi, A. A., Contoli, M., Adcock, I. M., Bellettato, C. M., Padovani, A., Casolari, P., Stanciu, L. A., Barnes, P. J., Johnston, S. L., Ito, K., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.028 · Cited by 92
Cushing’s syndrome in children and adolescents: Current diagnostic and therapeutic strategies
MAGIAKOU, A., & Chrousos, G. P. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343985 · Cited by 92
Armstrong, J., Harbron, C. G., Lea, S., Booth, G. C., Cadden, P., WREGGETT, K. A., & Singh, D. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180737 · Cited by 89
Targeting MicroRNA Function in Respiratory Diseases: Mini-Review
Maltby, S., Plank, M. W., Tay, H. L., Collison, A., & Foster, P. S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00021 · Cited by 82
Epigenetics in asthma and COPD
Kabesch, M., & Adcock, I. M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.07.017 · Cited by 81
Chang, P., Bhavsar, P. K., Michaeloudes, C., Khorasani, N. M., & Chung, K. F. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.017 · Cited by 79
van den Berge, M., Steiling, K. A., Timens, W., Hiemstra, P. S., Sterk, P. J., Heijink, I. H., Liu, G., Alekseyev, Y. O., Lenburg, M. E., Spira, A. E., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202878 · Cited by 76
Glucocorticoids Regulate Tight Junction Permeability of Lung Epithelia by Modulating Claudin 8
Kielgast, F., Schmidt, H., Braubach, P., Winkelmann, V. E., Thompson, K. E., Frick, M., Dietl, P., & Wittekindt, O. H. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0071oc · Cited by 74
Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
Fenwick, P. S., Macedo, P., Kilty, I., Barnes, P. J., & Donnelly, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128757 · Cited by 73
Johnson, M. W. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200402-010ms · Cited by 73
Kanniess, F., Richter, K. R., Böhme, S., Jörres, R. A., & MAGNUSSEN, H. (2001) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0288 · Cited by 73
Chang, P., Michaeloudes, C., Zhu, J., Shaikh, N., Baker, J., Chung, K. F., & Bhavsar, P. K. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0314oc · Cited by 73
Oxidant-induced corticosteroid unresponsiveness in human bronchial epithelial cells
Heijink, I. H., van Oosterhout, A. J. M., Kliphuis, N. M., Jonker, M. R., Hoffmann, R. F., Telenga, E. D., Klooster, K., Slebos, D., ten Hacken, N., Postma, D. S., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203520 · Cited by 72
Hakim, A., Barnes, P. J., Adcock, I. M., & Usmani, O. S. (2013) · The FASEB Journal · doi:10.1096/fj.12-222604 · Cited by 68
Meta-Review: Adverse Effects of Inhaled Corticosteroids Relevant to Older Patients
Mattishent, K., Thavarajah, M., Blanco, P., Gilbert, D., Wilson, A. M., & Loke, Y. K. (2014) · Drugs · doi:10.1007/s40265-014-0202-z · Cited by 65
Corticosteroid insensitivity in severe asthma: significance, mechanisms and aetiology
Hew, M. J., & Chung, K. F. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02192.x · Cited by 56
Verhoog, N. J. D., Du Toit, A., Avenant, C., & Hapgood, J. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193672 · Cited by 56
Kadiyala, V., Sasse, S. K., Altonsy, M. O., Berman, R., Chu, H. W., Phang, T. L., & Gerber, A. N. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721217 · Cited by 56
Perry, M. M., Durham, A. L., Austin, P. J., Adcock, I. M., & Chung, K. F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612671 · Cited by 54
Phenotypic predictors of response to oral glucocorticosteroids in severe asthma
Kupczyk, M., Haque, S., Middelveld, R. J. M., Dahlén, B., & Dahlén, S.-E. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.07.014 · Cited by 52
How Variability in Clinical Phenotypes Should Guide Research into Disease Mechanisms in Asthma
Chung, K. F., & Adcock, I. M. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201304-087aw · Cited by 52
IFN-γ Reverses IL-2– and IL-4–Mediated T-Cell Steroid Resistance
Goleva, E., Li, L.-B., & Leung, D. Y. M. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0327oc · Cited by 49
Avenant, C., Ronacher, K., Stubsrud, E., Louw, A., & Hapgood, J. P. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.007 · Cited by 49
O’Connor, D., Adams, W. P., Chen, M., Daley‐Yates, P. T., Davis, J. D., Derendorf, H., Ducharme, M. P., Fuglsang, A., Herrle, M., Hochhaus, G., et al. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2011.0878 · Cited by 45
Su, R., Becker, A. B., Kozyrskyj, A. L., & HayGlass, K. T. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.033 · Cited by 42
Glucocorticoid Receptor Phosphorylation Modulates Transcription Efficacy through GRIP-1 Recruitment
Avenant, C., Kotitschke, A., & Hapgood, J. P. (2010) · Biochemistry · doi:10.1021/bi901956s · Cited by 41
Chen, Y., Watson, A. M., Williamson, C. D., Rahimi, M., Liang, C., Colberg-Poley, A. M., & Rose, M. C. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0009oc · Cited by 38
Corticosteroid modulation of immunoglobulin expression and B‐cell function in COPD
Lee, J. Y., Machin, M., Russell, K. E., Pavlidis, S. P., Zhu, J., Barnes, P. J., Chung, K. F., Adcock, I. M., & Durham, A. L. (2016) · The FASEB Journal · doi:10.1096/fj.201500135 · Cited by 37
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD
Ngkelo, A., Hoffmann, R. F., Durham, A. L., Marwick, J. A., Brandenburg, S. M., de Bruin, H. G., Jonker, M. R., Rossios, C., Tsitsiou, E., Caramori, G., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00077.2015 · Cited by 28
Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma
Vasavda, N., Eichholtz, T. J., Takahashi, A., Affleck, K., Matthews, J. G., Barnes, P. J., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.039 · Cited by 20
The importance of chronobiology to drug discovery
Farrow, S. N., Solari, R. C. E., & Willson, T. M. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.689283 · Cited by 19
Eberhart, K., Rainer, J., Bindreither, D., Ritter, I., Gnaiger, E., Kofler, R., Oefner, P. J., & Renner, K. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.12.010 · Cited by 16
Scott, D. A., Woods, B. S., Thompson, J. C., Clark, J. F., Hawkins, N., Chambers, M. G., Celli, B. R., & Calverley, P. M. A. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0138-4 · Cited by 16
Transcriptional Regulation of Inflammatory Genes Associated with Severe Asthma
Clifford, R. L., Coward, W. R., Knox, A. J., & John, A. E. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795429000 · Cited by 11
Grant, I. W. B. (1961) · BMJ · doi:10.1136/bmj.2.5269.1781 · Cited by 3
Research works printed but not linked: 11
- Adcock IM, Caramori G, Chung KF (2008b) New targets for drug development in asthma. Lancet 372(9643):1073–1087 · DOI · Paper page
- Brompton Hospital/Medical Research Council Collaborative Trial (1974) Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Lancet 2(7876):303–307
- Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S, Jia G, Ohri CM, Doran E, Vannella KM, Butler CA, Hargadon B, Sciurba JC, Gieseck RL, Thompson RW, White S, Abbas AR, Jackman J, Wu LC, Egen JG, Heaney LG, Ramalingam TR, Arron JR, Wynn TA, Bradding P (2015) TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 7(301):301
- Clark TJ (1982) Safety of inhaled corticosteroids. Eur J Respir Dis Suppl 122:235–242
- Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention. NHLBI/WHO Workshop report 2002. NHI Publication 02-3659. http://www.ginasthma.com. Accessed 11 May 2015
- Hochhaus G, Druzgala P, Hochhaus R, Huang MJ, Bodor N (1991) Glucocorticoid activity and structure activity relationships in a series of some novel 17 alpha-ether-substituted steroids: influence of 17 alpha-substituents. Drug Des Discov 8(2):117–125
- Hua G, Ganti KP, Chambon P (2016a) Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex. Proc Natl Acad Sci U S A 113(5):E635–E643
- Hua G, Paulen L, Chambon P (2016b) GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression. Proc Natl Acad Sci U S A 113(5):E626–E634
- Kupczyk M, Wenzel S (2012) U.S. and. European severe asthma cohorts: what can they teach us about severe asthma? J Intern Med 272(2):121–132
- Nannini LJ, Poole P, Milan SJ, Holmes R, Normansell R (2013) Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 11:CD003794
- Yang IA, Clarke MS, Sim EH, Fong KM (2012) Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 7:CD002991
Cited by
Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181
Deng, Y., Xia, X., Zhao, Y., Zhao, Z., Martinez, C., Yin, W., Yao, J., Hang, Q., Wu, W., Zhang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27349-7 · Cited by 157
Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review
Yan, Y., Fu, J., Kowalchuk, R. O., Wright, C. M., Zhang, R., Li, X., & Xu, Y. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-108 · Cited by 135
Uveitis Therapy: The Corticosteroid Options
Valdes, L., & Sobrin, L. (2020) · Drugs · doi:10.1007/s40265-020-01314-y · Cited by 106
How to manage patients with corticosteroids in oncology in the era of immunotherapy?
Aldea, M. D., Orillard, É., Mansi, L., Marabelle, A., Scotté, F., Lambotte, O., & Michot, J. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.032 · Cited by 102
Metadata
- Authors
- Adcock, I. M., & Mumby, S.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Adcock, Ian M.
- Venue
- Handbook of experimental pharmacology
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 237
- Pages
- 171-196
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W4211105534
- Cited by
- 131
- References
- 137
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 19 · 2023: 15 · 2022: 14 · 2021: 30 · 2020: 15 · 2019: 13 · 2018: 1 · 2017: 1 · 2016: 1
- FWCI
- 21.63
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Handbook of experimental pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Wellcome Trust
- British Heart Foundation (PG/14/27/30679)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoids, topical glucocorticosteroids, airway inflammation, glucocorticoid receptor, nuclear receptors, gene transcription, chemokines, cytokines, inhaled corticosteroids, glucocorticoid resistance, glucocorticoid adverse effects, anti-inflammatory agents
- MeSH terms
- Animals, Asthma, Glucocorticoids, Humans, Receptors, Glucocorticoid, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.